CAPTIVATE PRIMARY ANALYSIS OF FIRST‐LINE TREATMENT WITH FIXED‐DURATION IBRUTINIB PLUS VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)

CSL Tam, JN Allan, T Siddiqi, TJ Kipps, R Jacobs, S Opat, PM Barr, A Tedeschi, L Trentin, R Bannerji, S Jackson, B Kuss, C Moreno, E Szafer‐Glusman, K Russell, C Zhou, J Ninomoto, JP Dean, P Ghia, WG Wierda